Frank Follmann

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

CD8+ T cell responses recognizing immunodominant Chlamydia antigens fail to protect against infection.

CD8+ T cell responses recognizing immunodominant Chlamydia antigens fail to protect against infection.

Journal: iScience

Published: September 26, 2025

Post-exposure vaccine protection of CTH522/CAF®01 against reinfection with Chlamydia trachomatis requires Th1/Th17 but not Th2-immunity.

Post-exposure vaccine protection of CTH522/CAF®01 against reinfection with Chlamydia trachomatis requires Th1/Th17 but not Th2-immunity.

Journal: NPJ vaccines

Published: December 19, 2024

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial.

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial.

Journal: The Lancet. Infectious diseases

Published: August 05, 2024

Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infection.

Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infection.

Journal: EBioMedicine

Published: June 10, 2024

MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates.

MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates.

Journal: Nature communications

Published: March 14, 2024

Multimodal mucosal and systemic immune characterization of a non-human primate trachoma model highlights the critical role of local immunity during acute phase disease.

Multimodal mucosal and systemic immune characterization of a non-human primate trachoma model highlights the critical role of local immunity during acute phase disease.

Journal: PLoS neglected tropical diseases

Published: January 31, 2024

Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccination.

Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccination.

Journal: EBioMedicine

Published: December 15, 2023

An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial.

An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial.

Journal: The Lancet. Infectious diseases

Published: November 13, 2023

Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice.

Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice.

Journal: Nature communications

Published: June 22, 2023

A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma.

A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma.

Journal: Frontiers in immunology

Published: March 03, 2023

A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates.

A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates.

Journal: bioRxiv : the preprint server for biology

Published: March 03, 2023

Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model.

Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model.

Journal: Frontiers in immunology

Published: September 29, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026